Pharma Outsourcing igång på Stockholm Waterfront

Norrländsk life science går för högtryck

EQT:s köp av Recipharm nära fullbordan

Riskkapitalbolaget EQT har tagit kontroll över svenska CDMO-företaget Recipharm.

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark, CEO at RegSmart Life Science, reflects on drug repurposing.